Effects of Oxytocin on Neural Activation Patterns During Social Cognitive Tasks in Patients With Schizophrenia

Trial Profile

Effects of Oxytocin on Neural Activation Patterns During Social Cognitive Tasks in Patients With Schizophrenia

Active, no longer recruiting
Phase of Trial: Phase 0

Latest Information Update: 27 May 2016

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Acronyms MEG
  • Most Recent Events

    • 10 May 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016.
    • 09 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.
    • 09 Feb 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top